Sapacitabine - ≥98% , DNA inhibitor, CAS No.151823-14-2, DNA inhibitor

CAS: 151823-14-2 Cat. No.: S649020 分子式: C26H42N4O5 分子量: 490.64 PubChem CID: 153970
注文可能
GRADE & PURITY ≥98%
Synonyms
2'-C-cyano-2'-deoxy-1-arabinofuranosyl-N(4)-palmitoylcytosine | N-(1-((2R,3S,4S,5R)-3-cyano-4-hydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl)-2-oxo-1,2-dihydropyrimidin-4-yl)palmitamide | SAPACITABINE [USAN] | 1-(2-cyano-2-deoxy-beta-D-arabinofuranosyl)-4-
Storage
Store at -20°C
Shipped In
Ice chest + Ice pads
★
Size
USA
ドイツ (EU)*
Price
Qty
5mg
S649020-5mg
受注生産 · 8~12週間
$180.90
10mg
S649020-10mg
受注生産 · 8~12週間
$280.90
25mg
S649020-25mg
受注生産 · 8~12週間
$600.90
50mg
S649020-50mg
受注生産 · 8~12週間
$960.90
100mg
S649020-100mg
受注生産 · 8~12週間
$1,536.90
Enter a quantity for the sizes you want to add.
🧪

Why this grade

≥98% for sensitive chromatographic and analytical workflows requiring minimal baseline interference.

🌡

Storage & shipping

Store at -20°C Ships Ice chest + Ice pads Check lot-specific COA for exact specifications.

📋

Quality documents

SDS, COA, datasheet, and spec sheet available for download. Lot-specific COA accessible via lot number lookup.

📚

Literature proof

Cited in 0 peer-reviewed publications across chromatography, organic synthesis, and cross-coupling reactions.

概要

Sapacitabine is an orally available nucleoside analog proagent that is structurally related to cytarabine.

In Vitro

Concentrations of Sapacitabine required to achieve an IC 50 range from 3±0.6 μM for the colon cancer cell line HCT116 to 67±14 μM for the breast cancer cell line MDA-MB-435. Cell cycle analysis shows that 35% Sapacitabine-treated cells are arrested in late-S phase and 41% in G 2 /M phase. L1210 cells with deoxycytidine kinase (dCK) activity are sensitive to Sapacitabine, (IC 50 20±6 μM). In the docetaxel/Sapacitabine combinations, synergistic effects (CI<1) are observed when docetaxel is given before Sapacitabine in both cell lines. MCE has not independently confirmed the accuracy of these methods. They are for reference only.

In Vivo

On Day 14, the Sapacitabine (5 mg/kg)+vorinostat (33 mg/kg) group has a mean tumour volume of 245 mm 3 and a tumour growth inhibition (TGI) of 92%, whereas the Sapacitabine (15 mg/kg)+vorinostat (33 mg/kg) group has a mean tumour volume of 107 mm 3 and a TGI of 112%. MCE has not independently confirmed the accuracy of these methods. They are for reference only.

Animal administration

Female (nu/nu) mice are injected subcutaneously with 1×10 7 MV4-11 cells resuspended in 50% Matrigel at a single site on their flanks. Once tumour volumes are 126 to 256 mm 3 (16 days post-implantation) animals are pair matched by tumour size into treatment groups (minimum of six mice per group) with a mean tumour size of ~190 mm 3 . Tumour measurements are calculated using the formula: volume (mm 3 )=width 2 (mm)×length (mm)×0.5. Sapacitabine is administered once a day orally (5 or 15 mg/kg) for 4 days , followed by a 3-day break before another 4 days of treatment; dosing starts on the same day as distribution to the treatment groups . aladdin has not independently confirmed the accuracy of these methods. They are for reference only.

Form:Solid

IC50& Target:nucleoside analog

Specifications

同義語
2'-C-cyano-2'-deoxy-1-arabinofuranosyl-N(4)-palmitoylcytosine | N-(1-((2R,3S,4S,5R)-3-cyano-4-hydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl)-2-oxo-1,2-dihydropyrimidin-4-yl)palmitamide | SAPACITABINE [USAN] | 1-(2-cyano-2-deoxy-beta-D-arabinofuranosyl)-4-
仕様と純度
≥98%
生化学的・生理学的メカニズム
Sapacitabine is an orally available nucleoside analog proagent that is structurally related to cytarabine.
保管条件
Store at -20°C
入荷
Ice chest + Ice pads
この製品は冷冷この冷このこの製品の運送が必要です。地上およびその他の経済サービスは利用できません。
アクションタイプ
INHIBITOR
作用メカニズム
DNA inhibitor
純度
≥98%
製品の性質
ALogP5.2
名前と識別子
カノニカル・スマイルCCCCCCCCCCCCCCCC(=O)NC1=NC(=O)N(C=C1)C2C(C(C(O2)CO)O)C#N
IUPAC NameN-[1-[(2R,3S,4S,5R)-3-cyano-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-2-oxopyrimidin-4-yl]hexadecanamide
InChIKeyLBGFKUUHOPIEMA-PEARBKPGSA-N
INCHI1S/C26H42N4O5/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-23(32)28-22-16-17-30(26(34)29-22)25-20(18-27)24(33)21(19-31)35-25/h16-17,20-21,24-25,31,33H,2-15,19H2,1H3,(H,28,29,32,34)/t20-,21+,24-,25+/m0/s1
異性体SMILES CCCCCCCCCCCCCCCC(=O)NC1=NC(=O)N(C=C1)[C@H]2[C@H]([C@@H]([C@H](O2)CO)O)C#N
代替CAS番号 151823-14-2
PubChem CID 153970
MeSH用語 2'-C-cyano-2'-deoxy-1-arabinofuranosyl-N(4)-palmitoylcytosine;CNDAC cpd;CS-682;CYC 682;CYC-682;sapacitabine
分子量 490.64

Documentation

📋 Safety Data Sheet (SDS)

Comprehensive hazard, handling, storage, and regulatory compliance document.

Download SDS →

✅ Certificate of Analysis (COA)

Lot-specific quality data. Enter your lot number to retrieve the exact COA.

Look up COA →

📊 Datasheet

Quick-reference summary of product specifications and applications.

View datasheet →

🔬 Specification Sheet

Full quality attributes and acceptance criteria for this grade.

View spec sheet →

Advanced Data

Taxonomic Classification

Taxonomy Tree

KingdomOrganic compounds
SuperclassNucleosides, nucleotides, and analogues
分類Pyrimidine nucleosides
SubclassPyrimidine 2'-deoxyribonucleosides
Intermediate Tree Nodes Not available
Direct ParentPyrimidine 2'-deoxyribonucleosides
Alternative Parents N-arylamides  Pyrimidones  Fatty amides  Imidolactams  Hydropyrimidines  Tetrahydrofurans  Heteroaromatic compounds  Secondary carboxylic acid amides  Secondary alcohols  Azacyclic compounds  Oxacyclic compounds  Nitriles  Hydrocarbon derivatives  Organic oxides  Organopnictogen compounds  Carbonyl compounds  Primary alcohols  
Molecular FrameworkAromatic heteromonocyclic compounds
Substituents Pyrimidine 2'-deoxyribonucleoside - N-arylamide - Pyrimidone - Fatty amide - Hydropyrimidine - Pyrimidine - Fatty acyl - Imidolactam - Heteroaromatic compound - Tetrahydrofuran - Carboxamide group - Secondary alcohol - Secondary carboxylic acid amide - Carboxylic acid derivative - Carbonitrile - Nitrile - Oxacycle - Azacycle - Organoheterocyclic compound - Organooxygen compound - Organonitrogen compound - Carbonyl group - Organopnictogen compound - Primary alcohol - Organic oxide - Hydrocarbon derivative - Organic nitrogen compound - Alcohol - Organic oxygen compound - Aromatic heteromonocyclic compound
説明This compound belongs to the class of organic compounds known as pyrimidine 2'-deoxyribonucleosides. These are compounds consisting of a pyrimidine linked to a ribose which lacks a hydroxyl group at position 2.
External Descriptors Not available
3 D構造
インタラクティブ化学構造モデル





証明書(CoA、COO、BSE/TSEと分析図)
C of A & Other Certificates(BSE/TSE, COO):
Analytical Chart:
化学的性質と物理的性質
溶解度DMSO : 33.33 mg/mL (67.93 mM; Need ultrasonic)
分子量490.600 g/mol
XLogP35.200
Hydrogen Bond Donor Count3
Hydrogen Bond Acceptor Count6
Rotatable Bond Count17
Exact Mass490.316 Da
Monoisotopic Mass490.316 Da
Topological Polar Surface Area135.000 Ų
Heavy Atom Count35
Formal Charge0
Complexity775.000
Isotope Atom Count0
Defined Atom Stereocenter Count4
Undefined Atom Stereocenter Count0
Defined Bond Stereocenter Count0
Undefined Bond Stereocenter Count0
The total count of all stereochemical bonds0
Covalently-Bonded Unit Count1
ソリューション計算機
レビュー

顧客レビュー

よくある質問

What is the purity of this product?
This product is supplied at ≥98% purity (chemical assay). Lot-specific values are stated on the Certificate of Analysis.
How should this product be stored?
Store at ?20 °C. Freezer storage is required to maintain the specified shelf life.
How is this product shipped?
This product ships in an insulated container with ice pads. Unpack on arrival and transfer it to the storage condition stated above.
What are the CAS number, molecular formula and molecular weight?
The CAS Number is 151823-14-2, the molecular formula is C26H42N4O5, and the molecular weight is 490.64 g/mol. InChIKey LBGFKUUHOPIEMA-PEARBKPGSA-N.
What documentation is provided?
Available product documentation, including Certificates of Analysis (COA), Safety Data Sheets (SDS), and specification sheets, is shown in the product document area. Document availability and access follow the current site policy.

Shall we send you a message when we have discounts available?

Remind me later

Thank you! Please check your email inbox to confirm.

Oops! Notifications are disabled.